| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Molecular Targets, and Chemical Biology |
Department of Biomedical Sciences, School of Public Health and Center for Excellence in Cancer Genomics, University at Albany, State University of New York, Rensselaer, New York
Requests for reprints: Julio Aguirre-Ghiso, Gen*NY*Sis Center For Excellence in Cancer Genomics, Room 216, 1 Discovery Drive, Rensselaer, NY 12144-3456. Phone: 518-591-7152; Fax: 518-591-7201; E-mail: jaguirre-ghiso{at}albany.edu.
It has been proposed that occult, disseminated metastatic cells are refractory to chemotherapy due to lack of proliferation. We have shown that p38 activation induces dormancy of squamous carcinoma cells. We now show that p38 signaling in these cells activates a prosurvival mechanism via the up-regulation of the endoplasmic reticulum (ER) chaperone BiP and increased activation of the ER stress–activated eukaryotic translation initiator factor 2
kinase RNA-dependent protein kinase–like ER kinase (PERK) allowing dormant tumor cells to resist drug toxicity. RNA interference and dominant-negative expression studies revealed that both BiP and PERK signaling promote survival and drug resistance of dormant cells, and that BiP up-regulation prevents Bax activation. We propose that stress-dependent activation of p38 via BiP up-regulation and PERK activation protects dormant tumor cells from stress insults, such as chemotherapy. (Cancer Res 2006; 66(3): 1702-1711)
This article has been cited by other articles:
|
|
 |
|
  T. Racek, S. Buhlmann, F. Rust, S. Knoll, V. Alla, and B. M. Putzer Transcriptional Repression of the Prosurvival Endoplasmic Reticulum Chaperone GRP78/BIP by E2F1 J. Biol. Chem., December 5, 2008; 283(49): 34305 - 34314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Virrey, D. Dong, C. Stiles, J. B. Patterson, L. Pen, M. Ni, A. H. Schonthal, T. C. Chen, F. M. Hofman, and A. S. Lee Stress Chaperone GRP78/BiP Confers Chemoresistance to Tumor-Associated Endothelial Cells Mol. Cancer Res., August 1, 2008; 6(8): 1268 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Feaver, N. E. Hastings, A. Pryor, and B. R. Blackman GRP78 Upregulation by Atheroprone Shear Stress Via p38-, {alpha}2{beta}1-Dependent Mechanism in Endothelial Cells Arterioscler. Thromb. Vasc. Biol., August 1, 2008; 28(8): 1534 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Schewe and J. A. Aguirre-Ghiso ATF6{alpha}-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo PNAS, July 29, 2008; 105(30): 10519 - 10524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Ranganathan, S. Ojha, A. Kourtidis, D. S. Conklin, and J. A. Aguirre-Ghiso Dual Function of Pancreatic Endoplasmic Reticulum Kinase in Tumor Cell Growth Arrest and Survival Cancer Res., May 1, 2008; 68(9): 3260 - 3268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Dong, M. Ni, J. Li, S. Xiong, W. Ye, J. J. Virrey, C. Mao, R. Ye, M. Wang, L. Pen, et al. Critical Role of the Stress Chaperone GRP78/BiP in Tumor Proliferation, Survival, and Tumor Angiogenesis in Transgene-Induced Mammary Tumor Development Cancer Res., January 15, 2008; 68(2): 498 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Lefranc, V. Facchini, and R. Kiss Proautophagic Drugs: A Novel Means to Combat Apoptosis-Resistant Cancers, with a Special Emphasis on Glioblastomas Oncologist, December 1, 2007; 12(12): 1395 - 1403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rahmani, E. M. Davis, T. R. Crabtree, J. R. Habibi, T. K. Nguyen, P. Dent, and S. Grant The Kinase Inhibitor Sorafenib Induces Cell Death through a Process Involving Induction of Endoplasmic Reticulum Stress Mol. Cell. Biol., August 1, 2007; 27(15): 5499 - 5513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-Q. Wang, Z.-X. Du, H.-Y. Zhang, and D.-X. Gao Different Induction of GRP78 and CHOP as a Predictor of Sensitivity to Proteasome Inhibitors in Thyroid Cancer Cells Endocrinology, July 1, 2007; 148(7): 3258 - 3270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Lee GRP78 Induction in Cancer: Therapeutic and Prognostic Implications Cancer Res., April 15, 2007; 67(8): 3496 - 3499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Fu, J. Li, and A. S. Lee GRP78/BiP Inhibits Endoplasmic Reticulum BIK and Protects Human Breast Cancer Cells against Estrogen Starvation-Induced Apoptosis Cancer Res., April 15, 2007; 67(8): 3734 - 3740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lee, P. Nichols, D. Spicer, S. Groshen, M. C. Yu, and A. S. Lee GRP78 as a Novel Predictor of Responsiveness to Chemotherapy in Breast Cancer Cancer Res., August 15, 2006; 66(16): 7849 - 7853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Koumenis and B. G. Wouters "Translating" Tumor Hypoxia: Unfolded Protein Response (UPR)-Dependent and UPR-Independent Pathways Mol. Cancer Res., July 1, 2006; 4(7): 423 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Drug Resistance Mechanism of Dormant Tumor Cells Cancer Res., March 15, 2006; 66(6): 3345 - 3345. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
